Tirzepatide

Order tirzepatide injections online. sold under the brand names Mounjaro and Zepbound, is an antidiabetic medication use for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered through subcutaneous injection (under the skin).

The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain.

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involve in blood-sugar control. After a person has eaten, these hormones are secreted by cells of the intestines, and in turn cause the secretion of insulin.

Tirzepatide is a GIP-analogue that activates both the GLP-1 and GIP receptors, leading to improve blood-sugar control. Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.

Order tirzepatide injections online

Tirzepatide was approve for medical use in the United States in May 2022, in the European Union in September 2022, in Canada in November 2022, and in Australia in December 2022.

The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. It was approve by the FDA for weight loss in November 2023, under the brand name Zepbound. In November 2023, the UK Medicines and Healthcare products Regulatory Agency revised the indication for tirzepatide to include treatment for weight loss.^[6][20]

Medical uses

Tirzepatide  indicates to improve blood-sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

Tirzepatide is also indicate as an adjunct to a reduce-calorie diet and increase physical activity for chronic weight management.Order tirzepatide injections online